Qualitative and quantitative validation of the FACIT-fatigue scale in iron deficiency anemia

Sarah Acaster, Rene Dickerhoof, Kendra DeBusk, Kristine Bernard, William Strauss, Lee F Allen, Sarah Acaster, Rene Dickerhoof, Kendra DeBusk, Kristine Bernard, William Strauss, Lee F Allen

Abstract

Background: Fatigue is a burdensome symptom in iron deficiency anemia (IDA). To capture the severity and impact of fatigue appropriately it must be measured using validated scales. This study evaluated the content validity and psychometric validity of the Functional Assessment of Chronic Illness Therapy - fatigue scale (FACIT-fatigue) in IDA patients.

Methods: Qualitative patient interviews were conducted in the United States to evaluate content validity. The psychometric properties of the FACIT-fatigue scale were investigated using data from a phase 3 clinical trial assessing ferumoxytol in patients with a history of unsatisfactory oral iron therapy or in whom oral iron cannot be used. The statistical analysis assessed the acceptability, reliability, validity and responsiveness of the FACIT-fatigue scale.

Results: Qualitative interviews showed that fatigue is a central concern to IDA patients and that the FACIT-fatigue scale sufficiently assessed this construct. Psychometric assessment demonstrated that the FACIT-fatigue scale was stable over time (ICC = 0.87) and internally consistent (α = 0.93). The scale demonstrated convergence with other conceptually relevant scales such as SF-36 Vitality (r = 0.74), and distinguished between known groups [i.e., treatment arms (mean difference (95 % CI) = 3.56 (1.68, 5.43), p <0.001) and high vs. low hemoglobin groups (mean difference (95 % CI) = 5.51 (8.59, 2.44) p <0.001)]. Responsiveness was also demonstrated; significant improvements in FACIT-fatigue scale scores corresponded with significant differences between minimal, moderate, and much improved vitality cohorts (p < 0.05).

Conclusions: This research demonstrated that the FACIT-fatigue scale has sound measurement properties and is an appropriate and interpretable assessment of fatigue among IDA patients with various underlying conditions.

Figures

Fig. 1
Fig. 1
FACIT-fatigue responsiveness: change from Baseline to Week 3 by hemoglobin and SF-36 Vitality domain. Hemoglobin groups: improved (≥1 g/dL), stable (0 -

References

    1. Killip S, Bennett JM, Chambers MD. Iron deficiency anemia. Am Fam Physician. 2007;75:671–8.
    1. Looker AC, Dallman PR, Carroll MD, Gunter EW, Johnson CL. Prevalence of iron deficiency in the United States. JAMA. 1997;277:973–6. doi: 10.1001/jama.1997.03540360041028.
    1. Cavill I, Auerbach M, Bailie GR, Barrett-Lee P, Beguin Y, Kaltwasser P, et al. Iron and the anaemia of chronic disease: a review and strategic recommendations. Curr Med Res Opin. 2006;22:731–7. doi: 10.1185/030079906X100096.
    1. World Health Organization . Prevalence of Anemia in Women. 1992.
    1. Clark SF. Iron deficiency anemia. Nutr Clin Pract. 2008;23:128–41. doi: 10.1177/0884533608314536.
    1. Rosenzweig PH, Volpe SL. Iron, thermoregulation and metabolic rate. Crit Rev Food Sci Nutr. 1999;39:131–48. doi: 10.1080/10408399908500491.
    1. Miller JF. Iron deficiency anemia: a common and curable disease. Cold Spring Harb Perspect Med. 2013;3:1–13. doi: 10.1101/cshperspect.a011866.
    1. Cella D, Kallich J, McDermott A, Xu X. The longitudinal relationship of hemoglobin, fatigue and quality of life in anemic cancer patients: results from five randomized clinical trials. Ann Oncol. 2004;15:979–86. doi: 10.1093/annonc/mdh235.
    1. Lind M, Vernon C, Cruickshank D, Wilkinson P, Littlewood T, Stuart N, et al. The level of haemoglobin in anaemic cancer patients correlates positively with quality of life. Br J Cancer. 2002;86:1243–9. doi: 10.1038/sj.bjc.6600247.
    1. Jacobsen PB, Garland LL, Booth-Jones M, Donovan KA, Thors CL, Winters E, et al. Relationship of hemoglobin levels to fatigue and cognitive functioning among cancer patients receiving chemotherapy. J Pain Symptom Manage. 2004;28:7–18. doi: 10.1016/j.jpainsymman.2003.11.002.
    1. Cella D, Lai JS, Chang CH, Peterman A, Slavin M. Fatigue in cancer patients compared with fatigue in the general United States population. Cancer. 2002;15:528–38. doi: 10.1002/cncr.10245.
    1. Yellen SB, Cella D, Webster K, Blendowski C, Kaplan E. Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symptom Manage. 1997;13:63–74. doi: 10.1016/S0885-3924(96)00274-6.
    1. Kosinski M, Gajria K, Fernandes AW, Cella D. Qualitative validation of the FACIT-Fatigue scale in systemic lupus erythematosus. Lupus. 2013;22:422–30. doi: 10.1177/0961203313476360.
    1. Lai JS, Beaumont JL, Ogale S, Brunetta P, Cella D. Validation of the functional assessment of chronic illness therapy-fatigue scale in patients with moderately to severely active systemic lupus erythematosus, participating in a clinical trial. J Rheumatol. 2011;38:672–9. doi: 10.3899/jrheum.100799.
    1. Cella D, Yount S, Sorensen M, Chartash E, Sengupta N, Grober J. Validation of the Functional Assessment of Chronic Illness Therapy Scale relative to other instrumentation in patients with rheumatoid arthritis. J Rheumatol. 2005;32:811–9.
    1. Chandran V, Bhella S, Schentag C, Gladman DD. Functional assessment of chronic illness therapy-fatigue scale is valid in patients with psoriatic arthritis. Ann Rheum Dis. 2007;66:936–9. doi: 10.1136/ard.2006.065763.
    1. Signorovitch J, Brainsky A, Grotzinger KM. Validation of the FACIT-Fatigue subscale, selected items from FACT-thrombocytopenia, and the SF36v2 in patients with chronic immune thrombocytopenia. Qual Life Res. 2011;20:1737–44. doi: 10.1007/s11136-011-9912-9.
    1. Hagell P, Hoglund A, Reimer J, Eriksson B, Knutsson I, Widner H, et al. Measuring fatigue in Parkinson’s disease: a psychometric study of two brief generic fatigue questionnaires. J Pain Symptom Manage. 2006;32:420–32. doi: 10.1016/j.jpainsymman.2006.05.021.
    1. U.S. Department of Health and Human Services Food and Drug Administration . Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims. 2009.
    1. Rothman M, Burke L, Erickson P, Leidy NK, Patrick DL, Petrie CD. Use of Existing Patient-reported Outcome (PRO) Instruments and their modification: The ISPOR good research practices for evaluating and documenting content validity for the use of existing instruments and their modification PRO task force report. Value Health. 2009;12:1075–83. doi: 10.1111/j.1524-4733.2009.00603.x.
    1. Vadhan-Raj S, Strauss W, Ford D, Bernard K, Boccia R, Li J, et al. Efficacy and safety of IV ferumoxytol for adults with iron deficiency anemia previously unresponsive to or unable to tolerate oral iron. Am J Hematol. 2014;89:7–12. doi: 10.1002/ajh.23582.
    1. Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36): I. conceptual framework and item selection. Med Care. 1992;30:473–83. doi: 10.1097/00005650-199206000-00002.
    1. Patrick DL, Gagnon DD, Zagari MJ, Mathijs R, Sweetenham J, Epoetin Alfa Study Group Assessing the clinical significance of health-related quality of life (HrQOL) improvements in anaemic cancer patients receiving epoetin alfa. Eur J Cancer. 2003;39:335–45. doi: 10.1016/S0959-8049(02)00628-7.
    1. McHorney CA, Ware JE, Jr, Raczek AE. The MOS 36-item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care. 1993;31:247–63. doi: 10.1097/00005650-199303000-00006.
    1. Maxwell C. Sensitivity and accuracy of the visual analogue scale: a psycho-physical classroom experiment. Br J Clin Pharmacol. 1978;6:15–24. doi: 10.1111/j.1365-2125.1978.tb01676.x.
    1. Joffe H, Yardley L. Content and thematic analysis. In: Marks D, Yardley L, editors. Research Methods for Clinical and Health Psychology. London: Sage; 2004. pp. 56–68.
    1. Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3:77–101. doi: 10.1191/1478088706qp063oa.
    1. Willis GB. Cognitive interviewing: a tool for improving questionnaire design. Thousand Oaks, California: Sage; 2005.
    1. Morse JM. The significance of saturation. Qual Health Res. 1995;5:147–9. doi: 10.1177/104973239500500201.
    1. Kerr C, Nixon A, Wild D. Assessing and demonstrating data saturation in qualitative inquiry supporting patient-reported outcomes research. Expert Rev Pharmacoecon Outcomes Res. 2010;10:269–81. doi: 10.1586/erp.10.30.
    1. McHorney CA, Tarlov AR. Individual patient monitoring in clinical practice: are available health status surveys adequate? Qual Life Res. 1995;4:293–307. doi: 10.1007/BF01593882.
    1. Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika. 1951;16:297–334. doi: 10.1007/BF02310555.
    1. Nunnally J. Psychometric Theory. New York, NY: McGraw-Hill; 1978.
    1. Scientific Advisory Committee of the Medical Outcomes Trust Assessing health status and quality-of-life instruments: attributes and review criteria. Qual Life Res. 2002;11:193–205. doi: 10.1023/A:1015291021312.
    1. Kline P. A handbook of test construction: introduction to psychometric design. New York, NY: Methuen; 1986.
    1. Nunnally JC, Bernstein IH. Psychometric theory. 3. New York, NY: McGraw-Hill; 1994.
    1. Wyrwich K, Norquist J, Lenderking W, Acaster S. Methods for interpreting change over time in patient-reported outcome measures. Qual Life Res. 2013;22:475–83. doi: 10.1007/s11136-012-0175-x.
    1. Acaster S, Swinburn P, Wang C, Stemper B, Beckmann K, Knappertz V. .: Can the Functional Assessment of Multiple Sclerosis adapt to changing needs? A psychometric validation in patients with clinically isolated syndrome and early relapsing–remitting multiple sclerosis. Multiple Sclerosis Journal; 2011;17:1504-1513.
    1. Lloyd AJ, Loftus J, Turner M, Lai G, Pleil A. Psychometric validation of the visual function questionnaire-25 in patients with diabetic macular edema. Health Qual Life Outcomes. 2013;11:10–21. doi: 10.1186/1477-7525-11-10.
    1. Prins MH, Guillemin I, Gilet H, Gabriel S, Essers B, Raskob G, et al. Scoring and psychometric validation of the Perception of Anticoagulant Treatment Questionnaire (PACT-Q) Health Qual Life Outcomes. 2009;7:30–42. doi: 10.1186/1477-7525-7-30.

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit